Sponsored Trials Arjo supports clinical trial research related to our products. Read all about our requirements for sponsor support or funding for clinical trials here.

Clinical evidence survey on Early Mobility in the ICU | Arjo Early mobilisation has been shown to be both safe and feasible for patients admitted to critical care. Download our clinical evidence summary.

About Arjo - For investors, shareholders and analysts Investors Arjo investor relations. Market-leading supplier of medical devices and solutions for patients with reduced mobility and age-related diseases. Visit us today!

An evaluation of 6 different sit to stand devices for use in rehabilitation shows an 'overwhelming preference' for the Sara® Flex knee support during a study in Loughborough University, UK.

Designed for the prevention and management of pressure injuries,¹ the Alpha Active® 3 pressure redistributing mattress overlay system is suitable for a range of care environments, including home and community care settings.

caregiver with lifting, supporting and positioning the limb for easier access when performing activities such as dressing, foot care, wound care and leg dressing. It is designed for single patient use.

When designing a care environment, people – in this case residents in long-term care settings and patients in acute care settings, as well as the caregivers – should be at the centre of the entire process. This focus is essential to achieve an attractive and efficient environment that stands the test of time.

Sufficient space is required in all areas in the care environment to provide the best opportunities for efficient care operations.

Interim report January-March 2021 The interim report for January-March 2021 will be published on April 27, 2021.

Interim Report January-June 2021 Arjo's interim report for January-June 2021 will be published on July 15, 2021.

Interim Report January-June 2020 Arjo's interim report for January-June 2020 will be published on July 17, 2020.